Matthew Young, PhD

Matthew Young, PhD

Associate Professor
Biochemistry and Molecular Biology

    About me

    Dr. Matthew J. Young received his BS and PhD degrees from the University of Manitoba. Dr. Young was a Postdoctoral Fellow at the National Institute of Environmental Health Sciences (NIEHS) and joined the Southern Illinois University School of Medicine faculty in 2015. The Young laboratory uses a variety of human cell culture, bioenergetic, molecular biology, and fluorescence microscopy techniques to study human mitochondrial function. The mission of our laboratory is to understand the cellular mechanisms that cause mitochondrial dysfunction in human health and disease. The aims of this research include determining how genetic mitochondrial disease mutations, as well as toxicants and drugs, disrupt mitochondrial function. We are currently investigating the off-target effects of drugs on mitochondria using a cell line model of liver cells, HepaRG. Also, we study human mtDNA maintenance in endometrial carcinoma. Lastly, we are designing and characterizing cell line models of mitochondrial disease.

    Gender

    Male

    Education & training

    Doctorate Degree
    PhD, University of Manitoba, Microbiology, Winnipeg, Manitoba
    Undergraduate Degree
    BS, University of Manitoba, Microbiology, Winnipeg, Manitoba
    Fellowship
    National Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, NC.

    Featured Publications

    [1] Suryadevara CM.  Donaldson H.  Khan HA.  Groff KJ.  Kim CD.  Dogra S.  Gautreaux J.  Roberts LG.  Young MG.  Snuderl M.  Zagzag D.  William CM.  McFaline-Figueroa JR.  Pilar Guillermo Prieto Eibl MD.  Cordova CA.  Kurz S.  Barbaro M.  Placantonakis DG.  Neoadjuvant PD1 blockade with laser interstitial thermal therapy for recurrent high-grade glioma.  2026 Mar;145():111823. 
    PMID: 41456377

    [2] Singh KPB.  Lee MD.  Young MG.  Orringer D.  Wang Y.  Snuderl M.  Jain R.  MRI-based prediction of DNA methylation grade in IDH-mutant astrocytomas using qualitative imaging features and tumor volumetrics.  2025 Dec;67(12):3509-3517. 
    PMID: 41217503

    [3] Wang A.  Young M.  Jiang J.  The Glyco-Switch of life: O-GlcNAcylation in cell fate decision.  2025 Nov;35(11):. 
    PMID: 41206509

    Grants

    Currently funded grants:

    Defining the cellular and molecular mechanisms of how toxicants disrupt mitochondrial DNA homeostasis. R15ES033394, National Institute of Environmental Health Sciences.

    Development of a novel endometrial cancer biomarker using mitochondrial DNA. The Simmons Cancer Institute at SIU (SCI) Team Science Grant (TSG).

    Past funded grants: 

    The Roles of Polymerase Gamma Accessory Subunit Gene Mutations in Human Disease. R00ES022638, National Institute of Environmental Health Sciences. 
     

    Related articles

    DNA strands

    Simmons Cancer Institute cross-dept. team publishes endometrial cancer study findings

    A team of SIU medical research scientists recently had their cancer study results published in a special issue of the international, peer-reviewed, open access journal Life.